PFM Health Sciences, LP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$8,130,045
+5.2%
10,423,135
+24.7%
0.38%
+27.7%
Q2 2023$7,730,449
+18.3%
8,357,242
+39.5%
0.30%
+4.2%
Q1 2023$6,531,902
-7.6%
5,992,571
+23.7%
0.29%
+13.8%
Q4 2022$7,071,525
-29.4%
4,843,510
-48.0%
0.25%
-30.3%
Q3 2022$10,020,000
-35.3%
9,320,584
+2.3%
0.36%
-38.6%
Q2 2022$15,487,000
+216.6%
9,109,780
+283.6%
0.59%
+223.0%
Q1 2022$4,892,000
-59.2%
2,374,674
-25.8%
0.18%
-55.3%
Q4 2021$12,004,000
-47.3%
3,201,066
-27.3%
0.41%
-38.9%
Q3 2021$22,766,000
+47.3%
4,403,574
+21.4%
0.67%
+38.2%
Q2 2021$15,455,000
+16.4%
3,627,900
+45.0%
0.48%
+19.2%
Q1 2021$13,282,000
-8.6%
2,501,303
-7.2%
0.41%
-20.5%
Q4 2020$14,525,000
+114.3%
2,694,769
+217.2%
0.51%
+63.3%
Q3 2020$6,779,000
-43.5%
849,440
-15.3%
0.31%
-7.4%
Q3 2015$12,005,000
-32.2%
1,002,953
+3.9%
0.34%
-24.6%
Q2 2015$17,698,000965,5150.45%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders